|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
1.05/0.98
|
企業價值
2.90B
|
資產負債 |
每股賬面淨值
5.26
|
現金流量 |
現金流量率
0.04
|
損益表 |
收益
482.38M
|
每股收益
4.32
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/16 22:02 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |